Investigational antibody demonstrates efficacy, safety for patients with aggressive multiple myeloma in phase I study

HIV-associated lymphoma responds well to stem cell transplantation

Stem cell transplantation safe for patients with HIV-associated lymphoma

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Post-transplant survival boosted by brentuximab vedotin in lymphoma

Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study

ecancermedicalscience editor's choice for November 2014

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion

Potential role of blood testing for microRNA profiles in paediatric cancers

Cancer genomics and pancreatic cancer

Fly models and genome sequencing

Prof Laskey receives Lifetime Achievement Prize